Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib

BACKGROUND: Targeted therapy is an important treatment for advanced non-small cell lung cancer (NSCLC) patients with specific genetic mutations, crizotinib can prolong survival in advanced NSCLC patients with echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase (EML4-ALK) rear...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Manag Res
Main Authors: Liang, Hongge, Ma, Di, Xu, Yan, Zhao, Jing, Chen, Minjiang, Liu, Xiaoyan, Zhong, Wei, Li, Junling, Wang, Mengzhao
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6733249/
https://ncbi.nlm.nih.gov/pubmed/31564978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S213572
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker